John H. Krystal, MD - PTSD: National Center for PTSD
Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

PTSD: National Center for PTSD

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
 

John H. Krystal, MD

Share this page

John H. Krystal, MD

John H. Krystal, MD

Director

Clinical Neurosciences Division

See staff directory for contact information.

Academic Appointment

  • Yale University, Robert L. McNeil, Jr., Professor of Translational Research; Professor of Psychiatry, Neuroscience, and Psychology; Chair, Department of Psychiatry

Education

  • Yale University, Psychiatry Residency, 1988
  • Yale University School of Medicine, M.D., 1984
  • University of Chicago, Behavioral Sciences, B.A., 1980

Expertise and Interests

  • Translational Neuroscience
  • Pharmacotherapy
  • Genetics

Membership in Professional Societies

  • U.S. National Academy of Medicine (Co-Director, Section 7; Psychiatry/Neurology, 2018-present)
  • Neuroscience Forum, U.S. National Academies of Science, Engineering, and Medicine (Co-Chair, 2019-present)
  • American College of Neuropsychopharmacology (President, 2012)
  • International College of Neuropsychopharmacology (President, 2016-2018)
  • Society of Biological Psychiatry (Council, 2006-present)
  • International Society of Traumatic Stress Studies (Board of Directors, 1988-1991)
  • Research Society on Alcoholism (Board of Directors, 2005-2009)

Awards and Honors

  • Colvin Prize, Brain and Behavior Research Foundation (2019)
  • Edward H. Ahrens, Jr. Distinguished Investigator Award, Association for Clinical and Translational Science (2019)
  • Gold Medal Prize, Society of Biological Psychiatry (2018)

Selected Publications

Davis, M.T., Hillmer, A., Holmes, S.E., Pietrzak, R.H., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G.A., Carson, R.E., Krystal, J.H., & Esterlis, I. (2019). In vivo evidence for dysregulation of mGluR5 as a biomarker of suicidal ideation. Proc Natl Acad Sci USA., 116(23), 11490-11495. doi: 10.1073/pnas.1818871116.

Holmes, S.E., Scheinost, D., Finnema, S.J., Naganawa, M., Davis, M.T., DellaGioia, N., Nabulsi, N., Matuskey, D., Angarita, G.A., Pietrzak, R.H., Duman, R.S., Sanacora, G., Krystal, J.H., Carson, R.E., & Esterlis, I. (2019). Lower synaptic density is associated with depression severity and network alterations. Nat Commun, 4; 10(1):1529. doi: 10.1038/s41467-019-09562-7.

Homan, P., Levy, I., Feltham, E., Gordon, C., Hu, J., Li, J., Pietrzak, R.H., Southwick, S., Krystal, J.H., Harpaz-Rotem, I., & Schiller, D. (2019). Neural computations of threat in the aftermath of combat trauma. Nat Neurosci, 22(3):470-476. doi: 10.1038/s41593-018-0315-x.

Krystal, J.H., Abdallah, C.G. Averill, L.A., Kelmendi, B., Harpaz-Rotem, I., Sanacora, G., Southwick, S.M., & Duman, R.S. (2017). Synaptic loss and the pathophysiology of PTSD: Implications for ketamine as a prototype novel therapeutic. Curr Psychiatry Rep, 19(10):74. doi: 10.1007/s11920-017-0829-z.

Holmes, S.E., Girgenti, M.J., Davis, M.T., Pietrzak, R.H., DellaGioia, N., Nabulsi, N., Matuskey, D., Southwick, S., Duman, R.S., Carson, R.E., Krystal, J.H., Esterlis, I., & Traumatic Stress Brain Study Group (2017). Altered metabotropic glutamate receptor 5 markers in PTSD: In vivo and postmortem evidence. Proc Natl Acad Sci U S A, 1;114(31):8390-8395. doi: 10.1073/pnas.1701749114.

Members of the press interested in scheduling an interview please see the contact for the media page.

Get help for PTSD

If you need help right away:

FacebookTwitterYouTube

PTSD Information Voice Mail:
(802) 296-6300
ncptsd@va.gov
Also see: VA Mental Health

Site Map